SpyGlass Pharma holder proposes $1.17M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SpyGlass Pharma, Inc. (SGP) shareholder Samsara BioCapital, L.P. reported a proposed sale of 37,166 common shares, with an approximate sale date of November 18, 2026 and an aggregate market value of $1,168,499.04. The shares were acquired from the issuer for cash in a private placement on July 6, 2023. Merrill Lynch is named as broker and Nasdaq as the exchange.
Key Figures
Key Terms
Private Placement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.